-+ 0.00%
-+ 0.00%
-+ 0.00%

Oncolys BioPharma hits upper limit on Tokyo Stock Exchange due to continued buying following the release of the world's first esophageal cancer drug.

NIKKEI QUICK·08/28/2026 04:27:07

Please log in to view news